Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Chromatogr Sci ; 57(4): 369-380, 2019 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-30615111

RESUMEN

The retention of 16 quinoline and tetrahydroquinoline derivatives was investigated under liquid chromatography conditions using porous graphitized carbon (PGC), octadecyl silica (ODS) and hypercrosslinked polystyrene (HCLP) stationary phases. For most of the analytes, retention on PGC was greater than on ODS, while retention on HCLP was even greater than on both ODS and PGC. The non-linearity of retention dependencies on acetonitrile content in the eluent was observed for compounds containing carboxy, hydrazo and methoxy groups. The relationships between quinolines structure and their retention factors were investigated. It was found that sorption on different sorbents correlated with different descriptors. Retention on ODS was found to be highly correlated with lipophilicity only while on HCLP it depended on both lipophilicity and polarizability of the sorbates. The feature of PGC was a good correlation of retention factors with topological and geometrical parameters. Additionally, ability of PGC to form OH…π bonds with hydroxymethylquinolines was found. The observed regularities allow one to rationally optimize the chromatographic analysis of structurally similar compounds, which is very important for bioactive substances.

2.
J Chromatogr A ; 1492: 55-60, 2017 Apr 07.
Artículo en Inglés | MEDLINE | ID: mdl-28262314

RESUMEN

The aim of our study was to investigate relationships between quinoline derivatives structure and their retention under reversed-phase liquid chromatography conditions. Retention factors of quinolines were experimentally measured and various geometrical and physicochemical parameters representing analytes molecular structure were calculated. Equations connecting chromatographic data with computed characteristics for the set of 17 investigated compounds were constructed. It was shown that the most precise dependencies include combination of physico-chemical and geometrical parameters.


Asunto(s)
Cromatografía Líquida de Alta Presión , Quinolinas/química , Cromatografía de Fase Inversa , Relación Estructura-Actividad Cuantitativa , Quinolinas/aislamiento & purificación
3.
Trials ; 12: 238, 2011 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-22053775

RESUMEN

BACKGROUND: Russia has particularly low life expectancy for an industrialised country, with mortality at working ages having fluctuated dramatically over the past few decades, particularly among men. Alcohol has been identified as the most likely cause of these temporal variations. One approach to reducing the alcohol problem in Russia is 'brief interventions' which seek to change views of the personal acceptability of excessive drinking and to encourage self-directed behaviour change. Very few studies to evaluate the efficacy of brief interventions in Russia have been conducted. Motivational Interviewing (MI) is a person-centred counselling style which can be adapted to brief interventions in which help is offered in thinking through behaviour in the context of values and goals, to decide whether change is needed, and if so, how it may best be achieved. METHODS: This paper reports on an individually randomised two-armed parallel group exploratory trial. The primary hypothesis is that a brief adaptation of MI will be effective in reducing self-reported hazardous and harmful drinking at 3 months. Participants were drawn from the Izhevsk Family Study II, with eligibility determined based on proxy reports of hazardous and harmful drinking in the past year. All participants underwent a health check, with MI subsequently delivered to those in the intervention arm. Signed consent was obtained from those in the intervention arm only at this point. Both groups were then invited for 3 and 12 month follow ups. The control group did not receive any additional intervention. RESULTS: 441 men were randomised. Of these 61 did not have a health check leaving 190 in each trial arm. Follow up at 3 months was high (97% of those having a health check), and very similar in the two trial arms (183 in the intervention and 187 in the control). No significant differences were detected between the randomised groups in either the primary or the secondary outcomes at three months in the intention to treat analyses. The unadjusted odds ratio (95% CI) for the effect of MI on hazardous and harmful drinking was 0.77 (0.51, 1.16). An adjusted odds ratio of 0.52 (0.28, 0.94) was obtained in the pre-specified per protocol analysis. CONCLUSIONS: This trial demonstrates that it is possible to engage Russian men who drink hazardously in a brief intervention aimed at reducing alcohol related harm. However the results with respect to the efficacy are equivocal and further, larger-scale trials are warranted. TRIAL REGISTRATION: ISRCTN: ISRCTN82405938.


Asunto(s)
Consumo de Bebidas Alcohólicas/prevención & control , Adulto , Humanos , Entrevistas como Asunto , Masculino , Persona de Mediana Edad , Motivación , Evaluación de Resultado en la Atención de Salud , Federación de Rusia
4.
Vaccine ; 25(21): 4312-23, 2007 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-17418918

RESUMEN

We have previously described designing of polyepitope immunogens TBI and TCI, to stimulate the humoral and cellular immune responses to HIV-1. Here, immunogens TBI and TCI were used to create new vaccine construct named CombiHIVvac (Combined HIV-1 vaccine). CombiHIVvac is a virus-like particles (VLP) containing the DNA vaccine pcDNA-TCI as a core encapsulated within a spermidine-polyglucin-TBI conjugate. The immunogenic and toxic properties of the candidate vaccine CombiHIVvac have been studied. CombiHIVvac induces a strong humoral and CTL responses in mice; the antibodies are highly specific and are able to neutralize HIV-1 in vitro. Preclinical study demonstrated that CombiHIVvac does not cause long-term changes in physiological, biochemical and morphological parameters in immunized animals and thus can be recommended for clinical trials.


Asunto(s)
Vacunas contra el SIDA/inmunología , Epítopos/inmunología , VIH-1/inmunología , Vacunas de ADN/inmunología , Vacunas de Virosoma/inmunología , Vacunas contra el SIDA/efectos adversos , Vacunas contra el SIDA/química , Animales , Western Blotting , Células Cultivadas , Citocinas/biosíntesis , Ensayo de Inmunoadsorción Enzimática , Epítopos/genética , Anticuerpos Anti-VIH/sangre , Humanos , Linfocitos/inmunología , Ratones , Ratones Endogámicos BALB C , Modelos Animales , Pruebas de Neutralización , Vacunas de ADN/efectos adversos , Vacunas de ADN/química , Vacunas de Virosoma/efectos adversos , Vacunas de Virosoma/química
5.
Vaccine ; 22(13-14): 1672-82, 2004 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-15068850

RESUMEN

A synthetic T cell immunogen (TCI) has been designed as a candidate DNA-based vaccine against Human immunodeficiency virus (HIV)-1 using cytotoxic T lymphocytes (CD8(+) CTL) and T-helper lymphocytes (CD4(+) Th) epitopes retrieved from the Los Alamos HIV Molecular Immunology Database. The protein 392 amino acids in length contains about eighty CTL-epitopes, many of which are overlapping and are totally restricted by ten different HLA class I molecules. To be able to detect CTL responses induced by a DNA vaccine in experimental animals, additional epitopes, restricted by mouse and Macaque rhesus major histocompatibility complex (MHC) class I molecules, were included in the target immunogen. The gene encoding the TCI protein was assembled, cloned into vector plasmids and expressed in a prokaryotic and a eukaryotic system. The presence of HIV-1 protein fragments in the immunogen structure was ascertained by ELISA and immunoblotting using panels of HIV-1-positive sera and monoclonal antibodies to p24. It has been demonstrated that DNA vaccine can induce both specific T cell responses (CTL and blast transformation) and specific antibodies in mice immunized with pcDNA-TCI.


Asunto(s)
Vacunas contra el SIDA/genética , Vacunas contra el SIDA/inmunología , Epítopos/genética , Epítopos/inmunología , Antígenos VIH/genética , Antígenos VIH/inmunología , VIH-1/genética , VIH-1/inmunología , Linfocitos T Citotóxicos/inmunología , Animales , Especificidad de Anticuerpos , Secuencia de Bases , División Celular , ADN Viral/genética , ADN Viral/inmunología , Diseño de Fármacos , Ensayo de Inmunoadsorción Enzimática , Escherichia coli/genética , Ingeniería Genética , Anticuerpos Anti-VIH/análisis , Anticuerpos Anti-VIH/biosíntesis , Humanos , Inmunoquímica , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Plásmidos/inmunología , Vacunas de ADN/inmunología
6.
Vaccine ; 22(13-14): 1692-9, 2004 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-15068852

RESUMEN

Two systems have been examined for delivery of DNA-vaccine encoding a HIV-1 polyepitope CTL-immunogen (TCI). One is intended for i.m. injection and is in the form of an artificial virus like particle containing eukaryotic expression plasmid pcDNA-TCI encapsulated within a spermidine-polyglucin conjugate. The other is intended for mucosal immunization and is based on attenuated Salmonella typhimurium strain 7207, which can deliver pcDNA-TCI directly into professional antigen-presenting cells (APC). After immunization, the artificial VLP and recombinant Salmonella induced an enhanced HIV specific serum antibody, proliferative and CTL responses compared to those induced by naked pcDNA-TCI. The most significant responses were produced when pcDNA-TCI was delivered by Salmonella.


Asunto(s)
Vacunas contra el SIDA/inmunología , VIH-1/inmunología , Salmonella/inmunología , Linfocitos T Citotóxicos/inmunología , Vacunas contra el SIDA/administración & dosificación , Administración Rectal , Animales , División Celular/fisiología , Medios de Cultivo , ADN Viral/inmunología , Ensayo de Inmunoadsorción Enzimática , Epítopos/inmunología , Inyecciones Intramusculares , Ratones , Microscopía de Fuerza Atómica , Plásmidos/inmunología , Vacunas de ADN/administración & dosificación , Vacunas de ADN/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...